Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 9Fallopian Tube Neoplasms 8Breast Neoplasms 6Neoplasms 5Carcinoma, Ovarian Epithelial 5Recurrence 3Prostatic Neoplasms 3Endometrial Neoplasms 3Small Cell Lung Carcinoma 2Metastatic Castration Resistant Prostate Cancer 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor, Unspecified, Adult 1Solid Tumor 1Prostate Cancer Metastatic 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related 1Lung Neoplasms 1Genital Neoplasms, Male 1Genital Neoplasms, Female 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Advanced Solid Tumors 1Advanced Solid Tumor 1Advanced Gastric Cancer 1Adenocarcinoma, Clear Cell 1Adenocarcinoma of Lung 1

Interventions

durvalumab 7Carboplatin 7Docetaxel 6Paclitaxel 5Nivolumab 5talazoparib 4linifanib 4Cisplatin 4trifluridine tipiracil drug combination 3tremelimumab 3tislelizumab 3depatuxizumab 3ST 1481 3S 1 (combination) 3Panobinostat 3Gemcitabine 3zimberelimab 2toripalimab 2olaparib 2motesanib diphosphate 2mogamulizumab 2TAS-114 2Sorafenib 2Rifampin 2PM 01183 2Oxaliplatin 2MLN 8237 2Itraconazole 2Injections 2Erlotinib Hydrochloride 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Solid Tumors × rucaparib × Clear all
NCT01009190 2023-06-08

A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens

pharmaand GmbH

Phase 1 Completed
85 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡